Flavonoid-Rich Dark Chocolate Improves Endothelial Function and Increases Plasma Epicatechin Concentrations in Healthy Adults

Journal of the American College of Nutrition

Volumn 23, Issue 3, 2004, Pages 197-204

  Engler, Mary B ^a   Engler, Marguerite M ^a   Browne, Amanda ^a   Chiu, Elisa Y ^a   Mietus Snyder, Michele L ^a   Paul, Steven M ^a   Malloy, Mary J ^a   Chen, Chung Y ^b   Kwak, Ho Kyung ^b   Milbury, Paul ^b   Blumberg, Jeffrey ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

8 isoprostanes; Chocolate; Cholesterol; Endothelial; Epicatechin; Flavonoid; Oxidized LDL

Indexed keywords

8 ISOPROSTANE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPICATECHIN; FLAVONOID; ISOPROSTANE DERIVATIVE; LIPID; LOW DENSITY LIPOPROTEIN; PROCYANIDIN; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; BODY MASS; BODY WEIGHT; BRACHIAL ARTERY; CACAO; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME ACTIVATION; FEMALE; HEART PROTECTION; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPID OXIDATION; MALE; NORMAL HUMAN; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; ANALYSIS OF VARIANCE; ANTIOXIDANTS; BIFLAVONOIDS; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; BRACHIAL ARTERY; CACAO; CANDY; CATECHIN; DOUBLE-BLIND METHOD; ENDOTHELIUM; FEMALE; FLAVONOIDS; HUMANS; LIPIDS; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; PROANTHOCYANIDINS; REFERENCE VALUES;

THEOBROMA; THEOBROMA CACAO;

EID: 2942516022     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2004.10719361     Document Type: Article

References (50)

1. Knekt P, Kumpulainen J, Järvinen R, Rissanen H, Heliövaara M, Reunanen A, Hakulinen T, Aromaa A: Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76:560-568, 2002.
2. Arts ICW, Jacobs DR, Harnack LJ, Gross M, Folsom AR: Dietary catechins in relation to coronary heart disease death among postmenopausal women. Epidemiology 12:668-675, 2001.
3. Yochum L, Kushi LH, Meyer K, Folsom AR: Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidermiol 149:943-949, 1999.
4. Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, Pekkarinen M, Simic BS, Toshima H, Feskens EJM, Hollman PCH, Katan MB: Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155:381-386, 1995.
5. Geleijnse JM, Launer LJ, van der Kuip DAM, Hofman A, Witteman JCM: Inverse association of tea and flavonoid intakes with incident myocardial infraction: the Rotterdam Study. Am J Clin Nutr 75:880-886, 2002.
6. Joshipura KJ, Ascherio A, Manson JE, Stampfer MJ, Rimm EB, Speizer FE, Hennekens CH, Spiegelman D, Willett WC: Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA 282:1233-1239, 1999.
7. Liu S, Manson JE, Lee IM, Cole SR, Hennekens CH, Willett WC, Buring JE: Fruit and vegetable intake and risk of cardiovascular disease: the Women’s Health Study. Am J Clin Nutr 72:922-928, 2000.
8. Joshipura KJ, Hu FB, Manson JE, Stampfer MJ, Rimm EB, Speizer FE, Colditz G, Ascherio A, Rosner B, Spiegelman D, Willett WC: The effect of fruit and vegetable intake on risk of coronary heart disease. Ann Int Med 134:1106-1114, 2001.
9. Liu S, Lee IM, Ajani U, Cole SR, Buring JE, Manson JE: Intake of vegetables rich in carotenoids and risk of coronary heart disease in men: The Physicians’ Health Study. Intl J Epidemiol 30:130-135, 2001.
10. Middleton E, Kandaswami C, Theoharides TC: The effects ofplant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmcol Rev 52:673-751, 2000.
11. Hammerstone JF, Lazarus SA, Schmitz HH: Procyanidin content and variation in some commonly consumed foods. J Nutr 130: 2086S-2092S, 2000.
12. Vinson JA, Proch J, Zubik L: Phenol antioxidant quantity and quality in foods: cocoa, dark chocolate, and milk chocolate. J Agric Food Chem 47:4821-4824, 1999.
13. Adamson GE, Lazarus SA, Mitchell AE, Prior RL, Cao G, Jacobs PH, Kremers BG, Hammerstone JF, Rucker RB, Ritter KA, Schmitz HH: HPLC method for quantification of procyanidins in cocoa and chocolate samples and correlation to total antioxidant capacity. J Agric Food Chem 47:4184-4188, 1999.
14. Steinberg FM, Holt RR, Schmitz HH, Keen CL: Cocoa procyanidin chain length does not determine ability to protect LDL from oxidation when monomer units are controlled. J Nutr Biochem 13:645-652, 2002.
15. Osakabe N, Baba S, Yasuda A, Iwamoto T, Kamiyama M, Takizawa T, Itakura H, Kondo K: Daily cocoa intake reduces the susceptibility of low-density lipoprotein to oxidation as demonstrated in healthy human volunteers. Free Rad Res 34: 93-99, 2001.
16. Wan Y, Vinson J, Etherton TD, Proch J, Lazarus SA, KrisEtherton PM: Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am J Clin Nutr 74:596-602, 2001.
17. Mathur S, Devaraj S, Grundy SM, Jialal I: Cocoa products decrease low density lipoprotein oxidative susceptibility but do not affect biomarkers of inflammation in humans. J Nutr 132:3663-3667, 2002.
18. Rein D, Paglieroni TG, Pearson DA, Wun T, Schmitz HH, Gosselin R, Keen CL: Cocoa and wine polyphenols modulate platelet activation and function. J Nutr 130:2120S-2126S, 2000.
19. Rein D, Paglierori TG, Wun J, Pearson DA, Schmitz HH, Gosselin R, Keen CL: Cocoa inhibits platelet activation and function. Am J Clin Nutr 72:30-35, 2000.
20. Rein D, Lotito S, Holt RR, Keen CL, Schmitz HH, Fraga CG: Epicatechin in human plasma: In vivo determination and effect of chocolate consumption on plasma oxidation status. J Nutr 130: 2109S-2114S, 2000.
21. Wang JF, Schramm DD, Holt RR, Ensunsa JL, Fraga CG, Schmitz HH, Keen CL: A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J Nutr 130:2115S-2119S, 2000.
22. Schramm DD, Wang JF, Holt RR, Ensunsa JL, Gonsalves JL, Lazarus SA, Schmitz HH, German JB, Keen CL: Chocolate procyanidins decrease the leukotriene-prostacyclin ratio in humans and human aortic endothelial cells. Am J Clin Nutr 73:36-40, 2001.
23. Karim M, McCormick K, Kappagoda CT: Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr 130:2105S-2108S, 2000.
24. Mao T, Van de Water J, Keen CL, Schmitz HH, Gershwin ME: Cocoa procyanidins and human cytokine transcription and secretion. J Nutr 130:2093S-2099S, 2000.
25. Schewe T, Sadik C, Klotz LO, Yoshimoto T, Kuhn H, Sies H: Polyphenols of cocoa: inhibition of mammalian 15-lipoxygenase. Biol Chem 382:1687-1696, 2001.
26. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. New Engl J Med 320:915-924, 1989.
27. Steinberg D, Lewis A: Conner Memorial Lecture: Oxidative modification of LDL and atherogenesis. Circulation 95:1062-1071, 1997.
28. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 105:1135-1143, 2002.
29. John S, Schmieder RE: Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences. J Hypertens 18:363-374, 2000.
30. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP: Close Relation of Endothelial Function in the Human Coronary and Peripheral Circulations. J Am Coll Cardiol 26:1235-1241, 1995.
31. Richelle M, Tavazzi I, Enslen M, Offord EA: Plasma kinetics in man of epicatechin from black chocolate. Eur J Clin Nutr 53:22-26, 1999.
32. Berkeley Nutrition Services: Questionnaire development and methodologic issues. http://www.nutritionquest.com/validation.htm (Accessed January 14, 2003).
33. Mietus-Snyder ML, Malloy MJ: Endothelial dysfunction occurs in children with three genetic hyperlipidemias: Improvement with antioxidant therapy. J Pediatr 133:35-40, 1998.
34. Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havel RJ: Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. J Am Med Assoc 264:3007-3012, 1990.
35. Friedewald WT, Levy RI, Fredrickson DS: Estimation of lowdensity lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18:499-502, 1972.
36. Milbury P: Analysis of complex mixtures of flavonoids and polyphenols by high-performance liquid chromatography electrochemical detection methods. Methods Enzymol 335:15-26, 2001.
37. Esterbauer H, Striegl G, Puhl H, Rotheneder M: Continuous monitoring of in vitro oxidation of human low-density lipoprotein. Free Rad Res Commun 6:67-75, 1989.
38. Ramos P, Gieseg SP, Schuster B, Esterbauer H: Effect of temperature and phase transition on oxidation resistance of low density lipoprotein. J Lipid Res 36:2113-2128, 1995.
39. Havel R, Eder H, Bragdon J: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1354-1353, 1955.
40. Esterbauer H, Gebicki J, Puhl H, Jurgens G: The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med 13:341-390, 1992.
41. Huang D, Ou B, Hampsch-Woodill M, Flanagan JA, Prior RL: High-throughput assay of oxygen radical absorbance capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96-well format. J Agric Food Chem 50:4437-4444, 2002.
42. Maclouf J, Grassi J, Pradelles P: Development of enzyme-immunoassay techniques for the measurement of eicosanoids. In Walden TL, Hughes HN (eds): “Prostaglandin and Lipid Metabolism in Radiation Injury.” Cambridge, MA: Perseus Publishing, pp 355-364, 1987.
43. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 39:257-265, 2002.
44. Freese R, Alfhan G, Jauhiainen M, Basu S, Erlund I, Salminen I, Aro A, Mutanen M: High intakes ofvegetables, berries, and apples combined with a high intake of linoleic or oleic acid only slightly affect markers of lipid peroxidation and lipoprotein metabolism in healthy subjects. Am J Clin Nutr 76:950-960, 2002.
45. Prior RL, Cao G: In vivo total antioxidant capacity: comparison of different analytical methods. Free Rad Bio Med 27:1173-1181, 1999.
46. Kris-Etherton PM, Mustad VA: Chocolate feeding studies: a novel approach for evaluating the plasma lipid effects of stearic acid. Am J Clin Nutr 60(Suppl):1029S-1036S, 1994.
47. Kris-Etherton PM, Derr JA, Mustad VA, Seligson FH, Pearson TA: Effects of a milk chocolate bar per day substituted for a high-carbohydrate snack in young men on an NCEP/AHA Step 1 diet. Am J Clin Nutr 60(Suppl):1037S-1042S, 1994.
48. Connor WE: Harbingers of coronary heart disease: dietary saturated fatty acids and cholesterol. Is chocolate benign because of its stearic acid content? Am J Clin Nutr 70:951-952, 1999.
49. Hodgson JM, Puddey IB, Beilin LJ, Mori TA, Croft KD: Supplementation with isoflavonoid phytoestrogens does not alter lipid concentrations: a randomized controlled trial in humans. J Nutr 128:728-732, 1998.
50. Simons LA, von Konigsmark M, Simons J, Celermajer DS: Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol 85:12971301, 2000